688265 南模生物
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-0.895-1.175-0.3045.97122.830
总资产报酬率 ROA (%)-0.783-1.016-0.2695.24415.479
投入资产回报率 ROIC (%)-0.811-1.056-0.2805.55015.292

边际利润分析
销售毛利率 (%)43.63242.37841.74460.86558.144
营业利润率 (%)-7.857-8.130-5.40424.64924.928
息税前利润/营业总收入 (%)-6.923-7.195-5.61825.09624.634
净利润/营业总收入 (%)-5.737-5.615-1.78222.11022.711

收益指标分析
经营活动净收益/利润总额(%)152.817132.267226.04088.89289.738
价值变动净收益/利润总额(%)-79.518-60.227-123.8783.3005.328
营业外收支净额/利润总额(%)0.0460.342-11.2601.765-0.064

偿债能力分析
流动比率 (X)7.0136.4797.47112.2202.317
速动比率 (X)6.9006.3917.36912.1162.193
资产负债率 (%)11.81613.06414.0129.18528.594
带息债务/全部投入资本 (%)5.3335.4585.1773.410--
股东权益/带息债务 (%)1,705.6661,654.9621,726.5342,776.211549.267
股东权益/负债合计 (%)746.331665.472613.699988.743249.720
利息保障倍数 (X)-7.384-7.4747.3816,302.691-88.555

营运能力分析
应收账款周转天数 (天)116.25298.54487.96870.6100.000
存货周转天数 (天)30.05428.06432.75144.7170.000